Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Group 1 – Healthy adults:
- Adults aged 18 or older who are willing and able to agree to take part in the study
- People who are generally healthy with no known eye problems other than needing glasses or contact lenses
- Women of childbearing age who complete a standard pregnancy screening evaluation before joining
Group 2 – Children:
- Children under 18 years of age who are patients at Duke Eye Center, either as regular ophthalmology clinic patients or scheduled for a medically necessary eye examination under anaesthesia at Duke Eye Center
- Cases where a healthcare provider familiar with the study agrees that the study team may contact the child's parent or legal guardian
- Children whose parent or legal guardian is willing and able to give consent for their child to take part
Who may not be able to join:
Group 1 – Healthy adults:
- People who are students or employees working directly under the supervision of the researchers running this trial
- People who have previously had problems with eye drops that widen (dilate) the pupil
- Women who are pregnant and would need to receive dilating eye drops as part of the study
Group 2 – Children:
- Children whose parent or legal guardian is unwilling or unable to provide consent for participation
- Children who have a health or eye condition that would prevent a standard eye examination or retinal imaging, such as cloudiness of the eye's lens or cornea (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (919)684-8434
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Presence of abnormal retinal microanatomy as measured by OCT reading; Severity of abnormal retinal microanatomy as measured by OCT reading; Retinal thickness at the fovea and surrounding optic nerve as measured by OCT analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.